RxDoctor Payments Data

Jared Gopman, MD

Surgery of the Hand · Dunedin, FLNPI 1497109847

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.1%), other and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Integra Lifesciences Corporation at 49.0% of the total. Reporting peaked in 2023 at $2,128 and has fallen 72.7% since, to $581 in 2025.

$3,664in general payments, 2019–2025

Across 52 payments — averaging $70.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$2K
  • Arthrex$777
  • Mentor Worldwide LLC$267
  • Acumed LLC$162
  • RTI Surgical, Inc$137
  • Merz North America, Inc.$132
  • plus $393 from 6 others

What the payments were for

  • Travel & lodging$77521%
  • Food & beverage$2,09157%
  • Other$79822%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,664 in reported general payments places this provider in the 55th percentile of 60 surgery of the hand providers in Florida.

See all surgery of the hand providers in Florida

Medicare billing

Part B allowed, 2024
$31,272
Medicare patients
37
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl23$95
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$63
Ondansetron Hcl12$53

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Dunedin

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →